- Patients to be given individual ‘lists’ of drugs depending on their tumour
- Cancer Research UK say plans will extend average survival rates
- Initial trial will involve 300 patients with lung cancer from 18 hospitals
- Researchers will start by assessing the genetic make-up of each tumour
- If successful patients with breast, prostate and bowel cancer could benefit from the ‘bespoke drugs service’ within the next two years
19:20 EST, 16 April 2014
|
02:41 EST, 17 April 2014
8
View
comments
Cancer patients could be given a tailor-made series of drugs to hugely boost their survival chances, experts say
Cancer patients could be given a tailor-made series of drugs to hugely boost their survival chances within the next two years, experts claim.
Patients with the deadliest types of the disease would be given individual ‘lists’ of drugs depending on the type of tumour.
Scientists from Cancer Research UK claim it will revolutionise the way the disease is treated and extend average survival rates for some types of cancer from four months to many years.
An initial trial will involve patients with lung cancer – the commonest but one of the most deadliest forms, claiming 35,000 lives in Britain a year.
If it is a success, patients with breast, prostate and bowel cancer could also be given the treatment within the next two years.
Over the next few months 300 patients with advanced lung cancer will be recruited to take part in the trial, which is being carried out at 18 hospitals in the UK.
Researchers will first carry out tests to determine the genetic make-up of each tumour in order to work out the types of drugs to be given.
Scientists hope it will give patients who are only expected to survive for four months the chance to live for many years.
Despite recent advancements in cancer treatment, the survival chances for certain types such as lung remain tragically low.
Around 43,500 Britons are diagnosed with lung cancer annually – just ten per cent of which live beyond five years.
Dr Harpal Kumar, chief executive of Cancer Research UK, said if the trial was successful, patients with breast, prostate and bowel cancer could be given the bespoke series of drugs within two years.
‘We are giving a number of options to patients who would otherwise have exhausted all their treatment,’ he said. ‘We are talking about the potential for thousands of patients to get another option.
‘I really believe that what we are doing is going to rewrite the rule book on how we do clinical trials.
Scientists from Cancer Research UK say the new treatment plans could be available within two years
‘It shifts the emphasis on designing a trial around a specific drug to designing a trial around a range of drugs for a specific patient.
‘So it’s much more patient- centric in its approach.
‘If it’s as successful as we expect it will be, we will fully then expect to roll it out to other types of cancer thereafter.’
The trial will be jointly run with the drug firms AstraZeneca and Pfizer, which are providing the treatments.
Recent figures from Cancer Research UK show the number of Britons diagnosed with cancer annually has soared by almost 50,000 in a decade. Some 330,000 cases were diagnosed in 2011, up from 283,000 in 2001.
The number included 50,000 with breast cancer, 40,695 with bowel cancer, 40,975 with prostate cancer, 42,026 with lung cancer and 12,818 with skin cancer.
Experts have blamed the rise on an ageing population, as well as obesity and alcohol consumption, which can trigger the disease.
Health Secretary Jeremy Hunt said: ‘By investing £11.5million a day into research and development for the life sciences we have made this country one of the best places in the world to carry out and invest in clinical trials, which has made ground-breaking programmes like this possible.’
or comment on this article
Kid taking selfie by tracks gets kicked in head by train…
Teen with Down Syndrome learns he’s going to college
Caught on camera. Florida teacher ‘orders attack’ on student
WATCH: Bullied boy turns the tables on his girl tormentor
Ukraine military deploys airborne troops in Kramatorsk
Emma Watson ‘unmasks’ to reveal Sofia Vergara underneath
Disturbing video: Man survives being run over by subway
John Daly hits tee shot out of model’s mouth
Chilling: Burglar looks over sleeping infant
Author Robin Saikia steers a boat round Venice’s sinister…
DEMO: Record shattering attraction drops riders 41-stories…
The CCTV that captures Banksy installing his latest creation
EDWARD LUCAS: I hope I’m wrong but historians may look back…
Florida teacher fired ‘after she ordered six students to…
Boy punched and kicked by girl ‘bully’ as NO ONE stepped in…
Now that’s photobooting! The moment foolish teen taking a…
‘I got ACCEPTED!’ The heartwarming moment of pure joy when a…
Even Donald Rumsfeld hates April 15: Politician reveals he…
Wu-Tang Clan-affiliated rapper cuts off his own penis before…
When two tribes go to war: Incredible moment legion of…
‘Women with large chests are expected to wear turtlenecks’:…
Mother goes on crack cocaine binge in Florida motel before…
Drama on the Royal tour: Pair ‘acting suspiciously’ and…
‘It could have been worse – she could have been doing…
Comments (8)
what you think
-
Newest -
Oldest -
Best rated -
Worst rated
The comments below have not been moderated.
FREESPEECHMAN,
LIVERPOOL, United Kingdom,
43 minutes ago
This seems to CONTRAST with The Tory Government Policy on Pension Projections and will play hell with their forecast of life expectancy.
Spiritus Veritas,
Berkshire, United Kingdom,
1 hour ago
As the pharmaceuticals know well cancer is a lucrative business that why the put so much effort in suppressing alternative cures.
comfortably numb,
cambridge,
2 hours ago
brilliant news, but once the drug companies put an unaffordable price on it and NICE say NO the average person on the street will see no difference as these drugs will become richpersons cures, whilst the rest suffer with being nuked with old fashioned radio therapy’s.
Bobs,
Hitchin,
42 minutes ago
royston amphlett,
bournemouth, United Kingdom,
2 hours ago
There’s a good use for those giant rats from Liverpool.
Elmgrove,
Brighton, United Kingdom,
2 hours ago
Hype? Makes it clear current methods are not successful – when will people realise that cancer is a natural response to an environmental context – and the way to a cure requires changing that context.
COLIN MAGOR,
MAGOR,
3 hours ago
THE DRUG COMPANIES ARE DESPERATE TO PROTECT THEIR INCOME AGAINST THE MANY CURES THAT ARE NOW AVAILABLE. THAT IS WHY SO MANY PEOPLE DO NOT KNOW ABOUT THESE CURES ON THE N.H.S. UNLESS YOU DIG DEEP YOURSELVES TO FIND OUT THAT GOES FOR STEM CELL AS WELL
cynical,
plymouth, United Kingdom,
7 hours ago
fine until NICE say “we can’t afford it †………….
The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.
Find out now